glp-1 drugs mechanism of action glp-1_analogs [TUSOM A Closer Look at the
Description
10.2337/dc14-2883 17 DaviesM.FrchL.JeppesenO
Public and private payers are gradually recognizing obesity as a chronic disease, improving affordability for eligible patients and encouraging physicians to prescribe GLP-1 therapies
However, online pharmacies are the fastest-growing distribution channel
Side effects are temporary : Digestive symptoms like nausea usually subside over time
doi: 10.1053/j.gastro.2022.08.045
Resmetirom and GLP-1 agonists for MASH: complementary rather than exclusive Resmetirom exhibits promising results as a specific treatment for MASH
